Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.56
+1.49 (1.67%)
At close: Oct 26, 2026, 4:00 PM EDT
90.12
-0.44 (-0.49%)
After-hours: Oct 26, 2026, 7:30 PM EDT
Edwards Lifesciences Employees
Edwards Lifesciences had 16,000 employees as of December 31, 2025. The number of employees increased by 200 or 1.27% compared to the previous year. That makes Edwards Lifesciences the 2,265th largest employer in the world and 547th in the United States.
Employees
16,000
Change (1Y)
200
Growth (1Y)
1.27%
Revenue / Employee
$407,019
Profits / Employee
$62,806
Market Cap
52.20B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16,000 | 200 | 1.27% |
| Dec 31, 2024 | 15,800 | -4,000 | -20.20% |
| Dec 31, 2023 | 19,800 | 2,500 | 14.45% |
| Dec 31, 2022 | 17,300 | 1,600 | 10.19% |
| Dec 31, 2021 | 15,700 | 800 | 5.37% |
| Dec 31, 2020 | 14,900 | 1,000 | 7.19% |
| Dec 31, 2019 | 13,900 | 1,100 | 8.59% |
| Dec 31, 2018 | 12,800 | 600 | 4.92% |
| Dec 31, 2017 | 12,200 | 1,100 | 9.91% |
| Dec 31, 2016 | 11,100 | 1,300 | 13.27% |
| Dec 31, 2015 | 9,800 | 700 | 7.69% |
| Dec 31, 2014 | 9,100 | 500 | 5.81% |
| Dec 31, 2013 | 8,600 | 400 | 4.88% |
| Dec 31, 2012 | 8,200 | 400 | 5.13% |
| Dec 31, 2011 | 7,800 | 800 | 11.43% |
| Dec 31, 2010 | 7,000 | 600 | 9.38% |
| Dec 31, 2009 | 6,400 | 200 | 3.23% |
| Dec 31, 2008 | 6,200 | 600 | 10.71% |
| Dec 31, 2007 | 5,600 | 50 | 0.90% |
| Dec 31, 2006 | 5,550 | 150 | 2.78% |
| Dec 31, 2005 | 5,400 | 200 | 3.85% |
| Dec 31, 2004 | 5,200 | 200 | 4.00% |
| Dec 31, 2003 | 5,000 | 0 | - |
| Dec 31, 2002 | 5,000 | 189 | 3.93% |
| Dec 31, 2001 | 4,811 | -289 | -5.67% |
| Dec 31, 2000 | 5,100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abbott Laboratories | 115,000 |
| Medtronic | 95,000 |
| Koninklijke Philips | 63,670 |
| Boston Scientific | 59,000 |
| Stryker | 56,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
EW News
- 3 days ago - Edwards Lifesciences added to ‘Core Ideas’ list at Evercore, Illumina removed - TheFly
- 5 days ago - 7 healthcare stocks that stand out as investors pay up for the sector - Market Watch
- 5 days ago - Edwards Lifesciences announces U.S. FDA approval of PASCAL Precision - TheFly
- 5 days ago - FDA Approval of Edwards Lifesciences' PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease - Business Wire
- 19 days ago - Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026 - Business Wire
- 20 days ago - Edwards Lifesciences initiated with an Overweight at Barclays - TheFly
- 21 days ago - Citi opens ‘upside 90-day catalyst watch’ on Edwards Lifesciences - TheFly
- 21 days ago - Edwards Lifesciences to Host Investor Event in Conjunction With TCT - Business Wire